Projects and Research

Renewal of Central Screening Registry ZORA – Zorica Project (2017–ongoing)

Towards Elimination of Cervical Cancer in Slovenia (2018–ongoing)

Renewal of Cervical Caner Screening Policy in Slovenia

Implementation of Liquid Based Technology (2019–ongoing)

Consolidation of ZORA programme Guidelines (2019–Jan 2022)

2021

• Ivanuš U, Jerman T, Gašper Oblak U, Meglič L, Florjančič M, Strojan Fležar M et al. The impact of the COVID-19 pandemic on organised cervical cancer screening: The first results of the Slovenian cervical screening programme and registry. Lancet Regional Health Europe. 2021:5:100101. doi: 10.1016/j.lanepe.2021.100101.
• Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P et al. The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 2021:148(2):277-84. doi: 10.1002/ijc.33189.
• Lozar T, Nagvekar R, Rohrer C, Dube Mandishora RS, Ivanus U, Fitzpatrick MB. Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer. Int J Womens Health. 2021:13:841-859. doi:10.2147/IJWH.S288376.
• Ritchie D, Arbyn M, Basu P, Corbex M, Fidarova E, Ivanuš U, et al. Europe’s Path to Eliminating Cervical Cancer as a Public Health Problem. The Lancet Regional Health - Europe. 2022:12:100276. doi: 10.1016/j.lanepe.2021.100276.
• Bokan T, Ivanus U, Jerman T, Takac I, Arko D. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme. Radiology and Oncology. 2021:55(2):187–95. doi: 10.2478/raon-2021-0001.
• Gajsek US, Dovnik A, Takac I, Ivanus U, Jerman T, Zatler SS, et al. Diagnostic performance of p16/Ki-67 dual immunostaining at different number of positive cells in cervical smears in women referred for colposcopy. Radiology and Oncology. 2021:55(4):426–32. doi: 10.2478/raon-2021-0043.

2020

• Jansen EEL, Ivanuš U, Jerman T, de Koning HJ, de Kok IMCM. The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia. Gynecol Oncol. 2020:S0090-8258(20)34058-0. doi: 10.1016/j.ygyno.2020.10.036.
• Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z et al. Response to the letter commenting on 'Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review'. Eur J Cancer. 2020:138:232-3. doi: 10.1016/j.ejca.2020.07.012.
• Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020:127:207-23. doi: 10.1016/j.ejca.2019.12.013.
• Prevodnik VK, Marinsek ZP, Zalar J, Rozina H, Kotnik N, Jerman T et al. Evaluation of the training program for p16/ Ki-67 dual immunocytochemical staining interpretation for laboratory staff without experience in cervical cytology and immunocytochemistry. Radiol Oncol. 2020:54(2):201-8. doi: 10.2478/raon-2020-0018.
• Gini A, Jansen EEL, Zielonke N, Meester RGS, Senore C, Anttila A, et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review. Eur J Cancer. 2020:127:224–35. doi: 10.1016/j.ejca.2019.12.014. 
• Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020:17(11):687–705. doi: 10.1038/s41571-020-0388-9. 
• Zielonke N, Gini A, Jansen EEL, Anttila A, Segnan N, Ponti A, et al. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review. European Journal of Cancer. 2020:127:191–206. doi: 10.1016/j.ejca.2019.12.010.

2019

• Prevodnik VK, Jerman T, Nolde N, Fokter AR, Jezeršek S, Pohar Marinšek Ž et al. Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears. Diagn Pathol. 2019:14(1):48. doi: 10.1186/s13000-019-0821-5.
• Varl J, Ivanus U, Marinsek ZP, Jerman T, Valencak AO, Poljak M et al. Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium. Radiol Oncol. 2019:53(3):316-22. doi: 10.2478/raon-2019-0044.
• Csanádi M, de Kok IM, Heijnsdijk EA, Anttila A, Heinävaara S, Pitter JG et al.  Key indicators of organized cancer screening programs: Results from a Delphi study. J Med Screen. 2019:26(3):120-6. doi: 10.1177/0969141318820362.

2018

• Ivanus U, Jerman T, Fokter AR, Takac I, Prevodnik VK, Marcec M et al. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiol Oncol. 2018:52(4):399-412. doi: 10.2478/raon-2018-0036.
• Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB et al. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer. 2018:(1):44-56. doi: 10.1002/ijc.31043.
• Turnbull E, Priaulx J, de Kok IMCM, Lansdorp-Vogelaar I, Anttila A, Sarkeala T et al. Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries. Health Policy. 2018:122(11):1206-11. doi: 10.1016/j.healthpol.2018.08.005.

2017

• Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in slovenia with the time trends analysis. Radiol Oncol. 2017:51(1):47-55. doi: 10.1515/raon-2017-0008.

2016

• Jančar N, Mihevc Ponikvar B, Tomšič S. Cold-knife conisation and large loop excision of transformation zone significantly increase the risk for spontaneous preterm birth: a population-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2016:203:245-9.  doi: 10.1016/j.ejogrb.2016.06.005.

2014

• Učakar V, Poljak M, Oštrbenk A, Klavs I. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening. J Med Virol. 2014:86(10):1772-9. doi: 10.1002/jmv.23997.

2013

• Maver PJ, Seme K, Korać T, Dimitrov G, Döbrőssy L, Engele L et al. Cervical cancer screening practices in central and eastern Europe in 2012. Acta Dermatovenerol Alp Pannonica Adriat. 2013:22(1):7-19. PubMed.

2009

• Anttila A, Ronco G; Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009:(15):2685-708. doi: 10.1016/j.ejca.2009.07.017.

2007

• Primic-Zakelj M, Repse-Fokter A. Cervical cancer screening: A Slovenian experience. Coll Antropol. 2007:31 Suppl 2:23-6. PubMed.

1992

• Pompe Kirn V, Kovacic J, Primic Zakelj M. Epidemiological evaluation of cervical cancer screening in Slovenia up to 1986. Eur J Gynaecol Oncol. 1992:13(1):75-82. PubMed.

1986

• Pompe Kirn V, Vrscaj Ursic M, Kovacic J, Primic Zakelj M. Epidemiological evaluation of early detection of cervical cancer in Slovenia till 1981. Eur J Gynaecol Oncol. 1986:7(3):147-51. PubMed.